Clover Health to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference
Clover Health (Nasdaq: CLOV) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. CEO Andrew Toy will deliver a presentation on Wednesday, January 15, 2025, at 4:30 p.m. Eastern Time. Investors and interested parties can access both the live webcast and replay of the presentation and Q&A session through Clover Health's investor relations website at investors.cloverhealth.com.
Clover Health (Nasdaq: CLOV) ha annunciato la sua partecipazione alla 43陋 Conferenza Annuale sulla Salute J.P. Morgan. Il CEO Andrew Toy presenter脿 un intervento mercoled矛 15 gennaio 2025, alle 16:30 ora orientale. Gli investitori e le parti interessate possono accedere alla diretta streaming e alla registrazione della presentazione e della sessione di domande e risposte attraverso il sito web delle relazioni con gli investitori di Clover Health su investors.cloverhealth.com.
Clover Health (Nasdaq: CLOV) ha anunciado su participaci贸n en la 43陋 Conferencia Anual de Salud J.P. Morgan. El CEO Andrew Toy realizar谩 una presentaci贸n el mi茅rcoles 15 de enero de 2025, a las 4:30 p.m. hora del Este. Los inversores y partes interesadas pueden acceder tanto a la transmisi贸n en vivo como a la repetici贸n de la presentaci贸n y la sesi贸n de preguntas y respuestas a trav茅s del sitio web de relaciones con los inversores de Clover Health en investors.cloverhealth.com.
Clover Health (Nasdaq: CLOV)電� 鞝�43須� J.P. 氇贝 項姢旒�鞏� 旎嵓霟办姢鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. CEO Andrew Toy電� 2025雲� 1鞗� 15鞚� 靾橃殧鞚� 鞓ろ泟 4鞁� 30攵� 霃欕秬 響滌鞁�鞐� 氚滍憸毳� 歆勴枆頃� 鞓堨爼鞛呺媹雼�. 韴瀽鞛� 氚� 甏�鞁� 鞛堧姅 攵勲摛鞚� Clover Health鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼鞚� investors.cloverhealth.com毳� 韱淀暣 氚滍憸 氚� 歆堨潣 鞚戨嫷 靹胳厴鞚� 鞁れ嫓臧� 鞗箘雮橃檧 鞛儩鞚� 氇憪 鞝戧芳頃� 靾� 鞛堨姷雼堧嫟.
Clover Health (Nasdaq: CLOV) a annonc茅 sa participation 脿 la 43e Conf茅rence Annuelle J.P. Morgan sur la Sant茅. Le CEO Andrew Toy fera une pr茅sentation le mercredi 15 janvier 2025, 脿 16h30 heure de l'Est. Les investisseurs et les parties int茅ress茅es peuvent acc茅der 脿 la transmission en direct ainsi qu'脿 la rediffusion de la pr茅sentation et de la session de questions-r茅ponses via le site Internet des relations investisseurs de Clover Health 脿 investors.cloverhealth.com.
Clover Health (Nasdaq: CLOV) hat die Teilnahme an der 43. j盲hrlichen J.P. Morgan Gesundheitskonferenz angek眉ndigt. CEO Andrew Toy wird am Mittwoch, den 15. Januar 2025, um 16:30 Uhr Eastern Time eine Pr盲sentation halten. Investoren und interessierte Parteien k枚nnen sowohl auf den Live-Stream als auch auf die Aufzeichnung der Pr盲sentation und der Frage-Antwort-Runde 眉ber die Investor-Relations-Website von Clover Health unter investors.cloverhealth.com zugreifen.
- None.
- None.
JERSEY CITY, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Remote-First Company -- Clover Health Investments, Corp. (Nasdaq: CLOV) (鈥淐lover,鈥� 鈥淐lover Health鈥� or the 鈥淐ompany鈥�), today announced that its Chief Executive Officer, Andrew Toy, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 4:30 p.m. Eastern Time.
A live webcast and replay of the presentation and Q&A session will be accessible from Clover Health's investor relations website at .
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we aim to extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology鈥檚 impact on , as well as the earlier identification and management of and .
Press Contact:
Andrew Still-Baxter
Investor Relations Contact:
Ryan Schmidt
FAQ
When is Clover Health (CLOV) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch Clover Health's (CLOV) J.P. Morgan Healthcare Conference presentation?
Who will represent Clover Health (CLOV) at the 2025 J.P. Morgan Healthcare Conference?
Which annual J.P. Morgan Healthcare Conference will CLOV be participating in?
